Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

6ZIE

Crystal structure of MCL-1 in complex with a neutralizing Alphabody CMPX-383B

6ZIE の概要
エントリーDOI10.2210/pdb6zie/pdb
分子名称CMPX-383B, Induced myeloid leukemia cell differentiation protein Mcl-1, ZINC ION, ... (4 entities in total)
機能のキーワードde novo protein design, 3 helical antiparallel coiled coil, cell penetrating alphabody mcl-1 neutralizing alphabody, antitumor protein
由来する生物種synthetic construct
詳細
タンパク質・核酸の鎖数2
化学式量合計33627.94
構造登録者
Pannecoucke, E.,Savvides, S.N.,Desmet, J.,Lasters, I. (登録日: 2020-06-25, 公開日: 2021-04-28, 最終更新日: 2024-11-20)
主引用文献Pannecoucke, E.,Van Trimpont, M.,Desmet, J.,Pieters, T.,Reunes, L.,Demoen, L.,Vuylsteke, M.,Loverix, S.,Vandenbroucke, K.,Alard, P.,Henderikx, P.,Deroo, S.,Baatz, F.,Lorent, E.,Thiolloy, S.,Somers, K.,McGrath, Y.,Van Vlierberghe, P.,Lasters, I.,Savvides, S.N.
Cell-penetrating Alphabody protein scaffolds for intracellular drug targeting.
Sci Adv, 7:-, 2021
Cited by
PubMed Abstract: The therapeutic scope of antibody and nonantibody protein scaffolds is still prohibitively limited against intracellular drug targets. Here, we demonstrate that the Alphabody scaffold can be engineered into a cell-penetrating protein antagonist against induced myeloid leukemia cell differentiation protein MCL-1, an intracellular target in cancer, by grafting the critical B-cell lymphoma 2 homology 3 helix of MCL-1 onto the Alphabody and tagging the scaffold's termini with designed cell-penetration polypeptides. Introduction of an albumin-binding moiety extended the serum half-life of the engineered Alphabody to therapeutically relevant levels, and administration thereof in mouse tumor xenografts based on myeloma cell lines reduced tumor burden. Crystal structures of such a designed Alphabody in complex with MCL-1 and serum albumin provided the structural blueprint of the applied design principles. Collectively, we provide proof of concept for the use of Alphabodies against intracellular disease mediators, which, to date, have remained in the realm of small-molecule therapeutics.
PubMed: 33771865
DOI: 10.1126/sciadv.abe1682
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.3 Å)
構造検証レポート
Validation report summary of 6zie
検証レポート(詳細版)ダウンロードをダウンロード

252816

件を2026-04-29に公開中

PDB statisticsPDBj update infoContact PDBjnumon